Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways
出版年份 2012 全文链接
标题
Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways
作者
关键词
-
出版物
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Volume 304, Issue 1, Pages G72-G86
出版商
American Physiological Society
发表日期
2012-10-27
DOI
10.1152/ajpgi.00328.2012
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals
- (2012) Young-Ah Moon et al. Cell Metabolism
- Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass
- (2012) Birgit Knebel et al. PLoS One
- Differing Endoplasmic Reticulum Stress Response to Excess Lipogenesis versus Lipid Oversupply in Relation to Hepatic Steatosis and Insulin Resistance
- (2012) Lu-Ping Ren et al. PLoS One
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
- (2011) Yu Li et al. Cell Metabolism
- Non-alcoholic fatty liver disease
- (2011) Briohny W. Smith et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Current therapeutic strategies in non-alcoholic fatty liver disease
- (2011) J. K. Dowman et al. DIABETES OBESITY & METABOLISM
- Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do
- (2011) Edward Lebovics et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis
- (2011) Kezhong Zhang et al. EMBO JOURNAL
- Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice
- (2011) Jiansheng Huang et al. FASEB JOURNAL
- Dissociation of Inositol-requiring Enzyme (IRE1α)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice
- (2011) Michael J. Jurczak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome proliferator-activated receptor-α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis
- (2011) Claire Z Larter et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
- (2011) Christian Thoma et al. JOURNAL OF HEPATOLOGY
- Genome-Wide Profiling of Liver X Receptor, Retinoid X Receptor, and Peroxisome Proliferator-Activated Receptor in Mouse Liver Reveals Extensive Sharing of Binding Sites
- (2011) M. Boergesen et al. MOLECULAR AND CELLULAR BIOLOGY
- Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment
- (2011) Briohny W. Smith et al. Nature Reviews Endocrinology
- Nonalcoholic Fatty Liver Disease
- (2011) Krzysztof Lukasz Kopec et al. NUTRITION IN CLINICAL PRACTICE
- Integrated Expression Profiling and Genome-Wide Analysis of ChREBP Targets Reveals the Dual Role for ChREBP in Glucose-Regulated Gene Expression
- (2011) Yun-Seung Jeong et al. PLoS One
- The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis
- (2011) Lisa B. Van Wagner et al. Therapeutic Advances in Gastroenterology
- Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
- (2010) Dina G. Tiniakos et al. Annual Review of Pathology-Mechanisms of Disease
- Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice
- (2010) Myoung-Su Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genetic control ofde novolipogenesis: role in diet-induced obesity
- (2010) Maggie S. Strable et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Fatty acid regulation of hepatic lipid metabolism
- (2010) Donald B Jump CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance
- (2010) David B Savage et al. CURRENT OPINION IN LIPIDOLOGY
- Palmitoylation of ketogenic enzyme HMGCS2 enhances its interaction with PPARα and transcription at the Hmgcs2 PPRE
- (2010) Morris A. Kostiuk et al. FASEB JOURNAL
- Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome
- (2010) J. Bernadette Moore PROCEEDINGS OF THE NUTRITION SOCIETY
- Peroxisome Proliferator-Activated Receptor Alpha Target Genes
- (2010) Maryam Rakhshandehroo et al. PPAR Research
- AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
- (2009) B. Viollet et al. Acta Physiologica
- AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
- (2009) Bei B. Zhang et al. Cell Metabolism
- Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
- (2009) C. H. KIM et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones
- (2009) Seong Hwan Hwahng et al. HEPATOLOGY
- Fenofibrate Simultaneously Induces Hepatic Fatty Acid Oxidation, Synthesis, and Elongation in Mice
- (2009) Maaike H. Oosterveer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GRP78 expression inhibits insulin and ER stress–induced SREBP-1c activation and reduces hepatic steatosis in mice
- (2009) Hélène L. Kammoun et al. JOURNAL OF CLINICAL INVESTIGATION
- Dephosphorylation of Translation Initiation Factor 2α Enhances Glucose Tolerance and Attenuates Hepatosteatosis in Mice
- (2008) Seiichi Oyadomari et al. Cell Metabolism
- Recent advances in nonalcholic fatty liver disease
- (2008) Victoria Greenfield et al. CURRENT OPINION IN GASTROENTEROLOGY
- UPR Pathways Combine to Prevent Hepatic Steatosis Caused by ER Stress-Mediated Suppression of Transcriptional Master Regulators
- (2008) D. Thomas Rutkowski et al. DEVELOPMENTAL CELL
- Causes and Metabolic Consequences of Fatty Liver
- (2008) Norbert Stefan et al. ENDOCRINE REVIEWS
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1
- (2008) A.-H. Lee et al. SCIENCE
- Current and Emerging Therapies in Nonalcoholic Fatty Liver Disease
- (2008) Maryam Kashi et al. SEMINARS IN LIVER DISEASE
- Fatty Liver
- (2007) Anna Kotronen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started